Your browser doesn't support javascript.
loading
Routine measurement of plasma chromogranin B has limited clinical utility in the management of patients with neuroendocrine tumours.
Monaghan, P J; Lamarca, A; Valle, J W; Hubner, R A; Mansoor, W; Trainer, P J; Darby, D.
Afiliación
  • Monaghan PJ; The Christie Pathology Partnership, The Christie NHS Foundation Trust, Manchester, UK.
  • Lamarca A; Department of Medical Oncology, The Christie NHS Foundation Trust and ENETS Centre of Excellence, Manchester, UK.
  • Valle JW; Department of Medical Oncology, The Christie NHS Foundation Trust and ENETS Centre of Excellence, Manchester, UK.
  • Hubner RA; Institute of Cancer Sciences, University of Manchester, Manchester, UK.
  • Mansoor W; Department of Medical Oncology, The Christie NHS Foundation Trust and ENETS Centre of Excellence, Manchester, UK.
  • Trainer PJ; Department of Medical Oncology, The Christie NHS Foundation Trust and ENETS Centre of Excellence, Manchester, UK.
  • Darby D; Department of Endocrinology, The Christie NHS Foundation Trust, Manchester, UK.
Clin Endocrinol (Oxf) ; 84(3): 348-52, 2016 Mar.
Article en En | MEDLINE | ID: mdl-26608723

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Tumores Neuroendocrinos / Cromogranina A / Cromogranina B Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Biomarcadores de Tumor / Tumores Neuroendocrinos / Cromogranina A / Cromogranina B Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Año: 2016 Tipo del documento: Article